Global News
Celltrion's Treatment for Autoimmune Diseases Launched in Five Key European Markets
Celltrion, a leading South Korean pharmaceutical company, has launched its autoimmune disease treatment, SteQeyma, in five major European countries. This biosimilar for ustekinumab aims to target…